Auro Laboratories Limited (BSE: 530233)
Health Care · Pharmaceuticals · IN
Rs236.60
-2.95% today · +7.1% 1Y
Auro Laboratories Limited (BSE: 530233) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $15.24M.
Over the last twelve months the share price has gained 7.1%, trading between 159.00 and 317.00.
Tweenvest scores Auro Laboratories Limited across four factors: quality 44/100, value 35/100, growth 36/100. Its strongest factor is quality.
530233 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.24M
- Revenue (TTM)
- $3.89M
- P/E
- 31.50
- EPS
- 7.51
- Dividend yield
- —
- Beta (5Y)
- 0.06
- 52-week high
- Rs317.00
- 52-week low
- Rs159.00
- Avg volume (3M)
- —
- Shares outstanding
- 6.23M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Devonian Health Group Inc.TSXV: GSD | $16.08M | CA$8.25 | +3.13% |
| Peak Processing LimitedASX: PKP | $15.83M | AU$0.02 | +6.25% |
| Otsuka Pakistan LimitedKASE: OTSU | $15.72M | PKRs359.78 | +0.79% |
| Bal Pharma LimitedBSE: 524824 | $15.32M | Rs93.15 | -11.79% |
| PeterLabs Holdings BerhadKLSE: PLABS | $15.16M | RM0.23 | +2.27% |
| Par Drugs and Chemicals LimitedNSEI: PAR | $14.89M | Rs117.10 | -5.53% |
| 1CM Inc.CNSX: EPIC | $14.85M | CA$0.18 | — |
| Thalia Therapeutics PlcAIM: THAT | $14.69M | £0.01 | -0.80% |
Figures last refreshed Oct 11, 2026.